Tech Company Financing Transactions
Loyal Animal Health Funding Round
Loyal Animal Health closed a $100 million Series C investment round on 2/11/2026. Investors included Baillie Gifford and private investors.
Transaction Overview
Company Name
Announced On
2/11/2026
Transaction Type
Venture Equity
Amount
$100,000,000
Round
Series C
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
548 Market Street 26099
San Francisco, CA 94104
USA
San Francisco, CA 94104
USA
Phone
Undisclosed
Website
Email Address
Overview
Loyal is a clinical-stage veterinary medicine company developing drugs intended to extend the healthspan and lifespan of dogs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Celine Halioua
Chief Medical Officer
Ellen Ratcliff
Chief Technical Officer
Wiwik Watanabe
VP - Bus. Development
Jill Isenstadt
VP - Bus. Development
Stefan Leape
VP - Product Management
Stan Berkow
VP - Product Management
Phelps Peeler
VP - R & D
Hubert Chen
VP - R & D
Matt Peloquin
VP - Regulatory Affairs
Melinda Poole
Browse more venture capital transactions:
Prev: 2/11/2026: Inertia Enterprises venture capital transaction
Next: 2/11/2026: Neara venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs